Author(s) Details:
Oderinlo Olufemi
Eye Foundation Hospital, GRA Ikeja, Lagos, Nigeria.
Bulus Stanley Sano
Department of Ophthalmology, Barau Dikko Teaching Hospital, Kaduna State University, Kaduna, Kaduna State, Nigeria.
Umeh Victor
Eye Foundation Hospital, GRA Ikeja, Lagos, Nigeria.
Lateefat Oshunkoya
|Eye Foundation Hospital, GRA Ikeja, Lagos, Nigeria.
Adekunle Hassan
Eye Foundation Hospital, GRA Ikeja, Lagos, Nigeria.
This section is a part of the chapter: Outcomes of Laser Photocoagulation for Goldberg Stage 3 Proliferative Sickle Cell Retinopathy (PSR) in an Eye Foundation Hospital: A Review
Sixty-two patients were diagnosed with PSR within the period under consideration. Patients ages ranged from 19 to 79 years old with a mean of 40.21 years and a standard deviation of ± 11.11 years; there were 35 (56.4%) males and 27 (43.6%) females (Olufemi et al., 2023.). A majority of the patients (49, 79.0%) had HB genotype SC, while the rest of the 13 patients (21%) had HB genotype SS (Olufemi et al., 2023.). The mean follow-up period was 3.5 years with a standard deviation of ± 3.4 years. Out of 122 eyes with VA records at presentation, 72 eyes (59.1%) had visual acuities better than 6/18 (mild or no visual impairment), 19 eyes (15.6%) had acuities between <6/18 and 6/60 (moderate visual impairment), and 17 eyes (13.9%) had visual acuities between <6/60 and 3/60 (severe visual impairment), while 14 eyes (11.4%) had VA <3/60 (blindness) (Olufemi et al., 2023.).
How to Cite
Olufemi, O., Sano, B. S., Victor, U., Oshunkoya, L., & Hassan, A. (2025). Outcomes of Laser Photocoagulation for Goldberg Stage 3 Proliferative Sickle Cell Retinopathy (PSR) in an Eye Foundation Hospital: A Review. Medical Science: Trends and Innovations Vol. 4, 143–151. https://doi.org/10.9734/bpi/msti/v4/4154